Skip to main content
Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract

Fig. 2

Cataract progression in different groups as observed by slit lamp microscope. The results are expressed as mean ± SD (n = 15). Compared with the model group (Group II), turbidity in the pirenoxine group (GroupVI) and all 3 treatment groups (Group III, IV, V) was significantly reduced, * P < 0.01, vs all other groups. Optimal effects were observed in the combination (Group V); ** P < 0.05, vs group III, IV

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us